Fe2O3-Co3O4 nanocomposite gas sensor for ethanol sensing studies

IF 44 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

The Lancet Diabetes & Endocrinology Pub Date : 2024-10-10 DOI:10.1016/j.ceramint.2024.10.138

Seyed Mohammad Hossein Bagherzadeh Enferadi, Ali Mirzaei

{"title":"Fe2O3-Co3O4 nanocomposite gas sensor for ethanol sensing studies","authors":"Seyed Mohammad Hossein Bagherzadeh Enferadi, Ali Mirzaei","doi":"10.1016/j.ceramint.2024.10.138","DOIUrl":null,"url":null,"abstract":"This study focused on pristine Fe2O3, pristine Co3O4, and Fe2O3-Co3O4 composite using the Pechini sol-gel method for ethanol gas sensing applications. Advanced characterization techniques were used to analyze the phase, morphology, and composition of the synthesized materials. Gas sensors were then fabricated and used for ethanol gas sensing at different temperatures. The results indicated that Fe2O3-Co3O4 composite gas sensor crystallized at 600°C, had higher response compared to both pristine Fe2O3 and pristine Co3O4 gas sensors. The composite sensor manifested a high response of 26.2 to 100 ppm ethanol at 250°C, while maximum responses of pristine Co3O4 gas sensor was only 4.4 at 200°C and that of pristine Fe2O3 sensor was 11.4 at 300°C. The boosted sensing performance of the composite sensor was related to the formation of p-n heterojunctions between Co3O4 and Fe2O3 in composite sensor, the formation of dangling bonds at interfaces, and high intrinsic ethanol sensing properties of Fe2O3.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"38 1","pages":""},"PeriodicalIF":44.0000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Diabetes & Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ceramint.2024.10.138","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

This study focused on pristine Fe₂O₃, pristine Co₃O₄, and Fe₂O₃-Co₃O₄ composite using the Pechini sol-gel method for ethanol gas sensing applications. Advanced characterization techniques were used to analyze the phase, morphology, and composition of the synthesized materials. Gas sensors were then fabricated and used for ethanol gas sensing at different temperatures. The results indicated that Fe₂O₃-Co₃O₄ composite gas sensor crystallized at 600°C, had higher response compared to both pristine Fe₂O₃ and pristine Co₃O₄ gas sensors. The composite sensor manifested a high response of 26.2 to 100 ppm ethanol at 250°C, while maximum responses of pristine Co₃O₄ gas sensor was only 4.4 at 200°C and that of pristine Fe₂O₃ sensor was 11.4 at 300°C. The boosted sensing performance of the composite sensor was related to the formation of p-n heterojunctions between Co₃O₄ and Fe₂O₃ in composite sensor, the formation of dangling bonds at interfaces, and high intrinsic ethanol sensing properties of Fe₂O₃.

查看原文本刊更多论文

用于乙醇传感研究的 Fe2O3-Co3O4 纳米复合气体传感器

本研究采用 Pechini 溶胶凝胶法，重点研究了用于乙醇气体传感的原始 Fe2O3、原始 Co3O4 和 Fe2O3-Co3O4 复合材料。研究采用了先进的表征技术来分析合成材料的相位、形态和成分。然后制作了气体传感器，并在不同温度下用于乙醇气体传感。结果表明，与原始 Fe2O3 和原始 Co3O4 气体传感器相比，在 600°C 结晶的 Fe2O3-Co3O4 复合气体传感器具有更高的响应。复合传感器在 250°C 时对 100 ppm 乙醇的响应高达 26.2，而原始 Co3O4 气体传感器在 200°C 时的最大响应仅为 4.4，原始 Fe2O3 传感器在 300°C 时的最大响应为 11.4。复合传感器传感性能的提高与复合传感器中 Co3O4 和 Fe2O3 之间形成 p-n 异质结、界面上形成悬空键以及 Fe2O3 固有的高乙醇传感性能有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Diabetes & Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

61.50

自引率

1.60%

发文量

371

期刊介绍： The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.